Dennis E Truxillo, CRNA | |
8212 Summa Ave, Baton Rouge, LA 70809-3421 | |
(225) 769-4403 | |
(225) 769-3842 |
Full Name | Dennis E Truxillo |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 17 Years |
Location | 8212 Summa Ave, Baton Rouge, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386805703 | NPI | - | NPPES |
RN087139 AP05377 | Other | LA | STATE LIC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | RN087139 AP05377 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Clinic Foundation | New orleans, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Entity Name | Anesthesiology Group Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Entity Name | Northlake Anesthesiologists, A Professional Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306949185 PECOS PAC ID: 3072597681 Enrollment ID: O20040614000209 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Entity Name | Youngs Professional Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Entity Name | Diversified Professionals, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700923992 PECOS PAC ID: 0446356463 Enrollment ID: O20070507000647 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dennis E Truxillo, CRNA 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 | Dennis E Truxillo, CRNA 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 |
News Archive
International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).
› Verified 7 days ago
Toni Tolar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8325 Kelwood Ave, Baton Rouge, LA 70806 Phone: 225-929-7600 Fax: 225-930-7524 | |
Holli B Cordell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-769-4403 Fax: 225-769-4403 | |
Amy Johnson, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 | |
Mrs. Courtney Day Passman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-765-3111 Fax: 225-765-3114 | |
Denise N Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Kaley Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-8541 | |
Alton J Ardoin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7855 Howell Blvd, Baton Rouge, LA 70807 Phone: 225-358-4900 |